Torrance, CANCT07503886Now EnrollingIRB Ready

Dry Eye Disease (DED) Clinical Trial in Torrance, CA

Access cutting-edge dry eye disease (ded) treatment through this clinical trial at a research site in Torrance. Study-provided care at no cost to qualified participants.

Sponsored by Dompé Farmaceutici S.p.A

Quick Self-Assessment

See if you qualify for this Torrance location

Preparing your pre-screening questions…

Expert Care in Torrance

Access dry eye disease (ded) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye disease (ded) treatment provided free

Apply for This Torrance Location

Check if you qualify for this dry eye disease (ded) clinical trial in Torrance, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Torrance

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Torrance site if eligible
  4. 4Begin participation

About This Dry Eye Disease (DED) Study in Torrance

This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in participants with dry eye disease. Approximately 417 participants aged 18 years or older who meet all eligibility criteria will be enrolled at study sites in the US. The study duration will be up to 16 weeks and will consist of three periods.

Sponsor: Dompé Farmaceutici S.p.A

Who Can Participate

Inclusion Criteria

A diagnosis of DED at least 6 months before enrollment (current use or recommended use of artificial tears for the treatment of dry eye).
The global score of the SANDE questionnaire ≥ 30
DED in at least one eye which is characterized by the following clinical features:
Schirmer I test without anesthesia \< 10 mm/5 minutes, and
Total CFS grade ≥ 4 assessed by the NEI grading system, and
Fluorescein tear film break-up time (TFBUT) \< 10 seconds.
Best corrected visual acuity (BCVA) score on early treatment of diabetic retinopathy study (ETDRS) chart of ≥ 35 letters (corresponding to ≥ 0.1 Snellen decimal units or ≤ 1.0 Logarithm of the Minimum Angle of Resolution (Chart) \[LogMAR\]) in each eye at the time of study enrollment.
Only participants who satisfy all informed consent requirements will be included in the study. Key

Exclusion Criteria

Inability to speak and understand the local language sufficiently to understand the nature of the study, to provide written informed consent, and to allow the completion of all study assessments.
Evidence of an active ocular infection in either eye.
Anticipated need for ocular surgery during the study period, or any prior ocular surgery for 6 months prior to screening.
Intraocular inflammation defined as anterior chamber cell or flare \> 0 by Standardization of Uveitis Nomenclature (SUN) grading in either eye.
Known or suspected ocular malignancy (ocular surface, intraocular, ocular adnexa) in either eye. Note: Additional protocol defined Inclusion/Exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Torrance?

Yes, this clinical trial (NCT07503886) has an active research site in Torrance, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Disease (DED) Treatment Options in Torrance, CA

If you're searching for dry eye disease (ded) treatment options in Torrance, CA, this clinical trial (NCT07503886) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Torrance research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry eye disease (ded) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye disease (ded) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Torrance, CA

See all ankylosing spondylitis clinical trials recruiting in Torrance — not just this study.

Browse Ankylosing Spondylitis Trials in Torrance →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsErectile Dysfunction TrialsDry Eye TrialsAll Conditions →

Ready to Join in Torrance?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Torrance, CA